Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2011 Aug;49(8):3054–3057. doi: 10.1128/JCM.01035-11

Controlled Comparison of BacT/Alert MB System, Manual Myco/F Lytic Procedure, and Isolator 10 System for Diagnosis of Mycobacterium tuberculosis Bacteremia

John A Crump 1,2,3,4,5,*, Anne B Morrissey 1, Habib O Ramadhani 4,5, Boniface N Njau 4,5, Venance P Maro 4,5, L Barth Reller 1,2
PMCID: PMC3147725  PMID: 21653761

Abstract

We compared the performance of the BacT/Alert MB system, that of the manual Bactec Myco/F Lytic procedure, and that of the Isolator 10 lysis-centrifugation system in the detection of Mycobacterium tuberculosis bacteremia. Mean times to detection were 16.4 days for BacT/Alert MB versus 20.0 days for Myco/F Lytic, 16.5 days for BacT/Alert MB versus 23.8 days for Isolator 10, and 21.1 days for Bactec Myco/F Lytic versus 22.7 days for Isolator 10. There were no significant differences in yields. The mean (range) magnitude of mycobacteremia was 30.0 (0.4, 90.0) CFU/ml and was correlated with the time to positivity in the BacT/Alert MB system (r = −0.4920). M. tuberculosis bacteremia was detected more rapidly in a continuously monitored liquid blood culture system, but the mean time to positivity exceeded 3 weeks.

TEXT

Mycobacterium tuberculosis bloodstream infection was described within a few decades of the discovery of the tubercle bacillus (7, 14). Disseminated tuberculosis remains a major health problem in countries where generalized HIV epidemics coincide with high tuberculosis incidence rates, often causing fatal illness in patients with immunologically advanced HIV disease (1, 46, 15, 17, 21). In-hospital case fatality rates for bacteremic disseminated tuberculosis in the era before the widespread availability of antiretroviral therapy approached 50% (1). Early recognition and treatment are likely to be important to avoid death (13).

Although the incremental value of mycobacterial blood culture for the diagnosis of disseminated tuberculosis has been both recognized and debated (10, 16, 19), there have been few evaluations of blood culture systems for the detection of M. tuberculosis (2, 3). Mycobacterial blood culture methods in common use include visual inspection of processed blood inoculated on a solid medium (e.g., the Isolator 10 system) and continuous detection in liquid medium inoculated with blood (e.g., the BacT/Alert MB system or the Bactec Myco/F Lytic system). In a mycobacterial blood culture study in the United States, we noted that bottles with M. tuberculosis were positive after a mean of 22.8 to 28.0 days of incubation, compared with 9.9 to 20.4 days for bottles with Mycobacterium avium complex (MAC) (11). In order to investigate the performance of mycobacterial blood culture methods for detecting M. tuberculosis bacteremia, we conducted a controlled study to compare the performances of the BacT/Alert MB system, the manual Bactec Myco/F Lytic procedure, and the Isolator 10 system for the detection of mycobacteremia among febrile patients admitted to two hospitals in northern Tanzania, a country experiencing a generalized HIV epidemic and a high incidence of tuberculosis.

Samples for blood cultures were collected from patients aged ≥13 years hospitalized at the Kilimanjaro Christian Medical Centre (KCMC) and Mawenzi Regional Hospital (MRH) in Moshi, Tanzania, from July 2006 through October 2009 (9). Patients with oral temperatures of ≥38.0°C were invited to participate in the study. Blood from all qualifying study participants was inoculated into a bioMérieux BacT/Alert mycobacterial (MB) bottle. In addition, blood from study participants with oral temperatures of ≥38.0°C, HIV infection, a fever duration of >1 month, and a presumed or measured weight loss of >10% was also inoculated into a Bactec Myco/F-Lytic bottle and a Wampole Isolator 10 lysis-centrifugation tube. Blood cultures were processed at KCMC.

Blood culture bottles were assessed for volume adequacy by comparing the weights before and after inoculation with blood. A bottle was included in the primary data analysis only if it contained 4 to 6 ml of blood. A secondary analysis was performed without reference to volume adequacy.

After assessment of the adequacy of the blood volume, MB bottles were loaded into the bioMérieux BacT/Alert 3D automated microbial detection system (bioMérieux Inc., Durham, NC), where they were incubated for 42 days. Bactec Myco/F-Lytic bottles (Becton Dickinson, Franklin Lakes, NJ) were incubated at 35°C for 42 days; bottle bottoms were examined for fluorescence daily using Wood's lamp. Isolator 10 lysis-centrifugation tubes were centrifuged and processed using the Wampole Isostat/Isolator Microbial System (Inverness Medical, Princeton, NJ), plated to Middlebrook 7H10 agar, and incubated at 35°C in 5% CO2 for 42 days. Bottles and plates with growth were processed according to standard techniques (20). AccuProbe Culture Identification Test MTB and MAC kits (Gen-Probe Inc., San Diego, CA) were used to identify M. tuberculosis complex and MAC members. Mycobacteria other than M. tuberculosis and MAC were identified at the National Institute for Public Health and the Environment, Bilthoven, the Netherlands (12, 23). Colonies growing on Middlebrook 7H10 plates from lysis-centrifugation specimens were counted, and numbers of CFU per ml of blood were calculated. Negative companion bottles from positive sets were subcultured at the end of the 42-day protocol.

Comparison of recovery rates was analyzed by the McNemar chi-square test with Yates' correction for small numbers when necessary (18). Times to detection were compared by the paired two-sample t test for means after log transformation was performed to correct for the observed positively skewed (nonparametric) distributions. All analyses were done with the SAS system for Windows (release 9.1; SAS Institute, Cary, NC).

This study was approved by the KCMC Research Ethics Committee, the Tanzania National Institutes for Medical Research National Research Ethics Coordinating Committee, and an Institutional Review Board of the Duke University Medical Center.

A total of 759 BacT/Alert MB blood cultures were processed; without restriction for volume adequacy, 26 (3.4%) yielded M. tuberculosis, 3 (0.4%) yielded M. sherrisii, and 77 (10.1%) yielded other pathogens, as shown in Table 1. Sixteen (2.1%) yielded organisms classified as contaminants. Of 20 complete (two bottles and one tube), adequately filled (5 ± 1 ml) sets from which M. tuberculosis was recovered from at least one bottle, the BacT/Alert MB system was positive for 12 (60.0%), the Bactec Myco/F Lytic procedure was positive for 20 (100.0%%), and the Isolator 10 system was positive for 9 (45.0%).

Table 1.

Clinically important organisms recovered from BacT/Alert MB bottles

Microorganism No. of sets in which organism was detected
M. tuberculosis complex 26
M. sherrisii 3
Salmonella enterica serovar Typhi 31
Escherichia coli 14
Streptococcus pneumoniae 12
Cryptococcus neoformans 7
Staphylococcus aureus 5
Nontyphoidal Salmonella 4
Klebsiella sp. 2
Brucella sp. 1
Pseudomonas aeruginosa 1

Table 2 shows the yields of M. tuberculosis for all three two-way comparisons of adequately filled pairs of bottles and for all bottles. For adequately filled pairs, although there were trends toward the manually read Bactec Myco/F Lytic bottle detecting M. tuberculosis more frequently than the BacT/Alert MB system and the Isolator 10 system, there were no significant differences between any two bottles compared. For all bottle pairs, there was also a trend toward the manually read Bactec Myco/F Lytic bottles detecting M. tuberculosis more frequently than the BacT/Alert MB system and the yield was significantly greater in the manually read Bactec Myco/F Lytic bottles than in the Isolator 10 system. Of 17 adequately filled MB bottles yielding M. tuberculosis, the mean (range) time to positivity was 22.6 (9.4 to 37.5) days. Of the three possible two-way comparisons of times to detection for adequate pairs of positive blood cultures, the mean time to detection was the shortest for the continuously monitored BacT/Alert MB system, followed by the manually read Bactec Myco/F Lytic bottle and the Isolator 10 system (Table 3). When all of the bottles were considered, the time to detection was significantly shorter for the BacT/Alert MB system than for both the manually read Bactec Myco/F Lytic bottle and the Isolator 10 system (Table 3). For 3 adequately filled MB bottles yielding M. sherrisii, the mean (range) time to positivity was 15.2 (7.7 to 27.3) days.

Table 2.

Comparative yields of M. tuberculosis obtained with various combinations of the BacT/Alert MB system, the manual Myco/F Lytic procedure, and the Isolator 10 system

Bottle pair (bottle 1, bottle 2) No. of bottles in which MTB was detected
P value
Both bottles Bottle 1 only Bottle 2 only
Adequately filled bottles
    BacT/Alert MB, Myco/F Lytic 6 2 5 0.4497
    BacT/Alert MB, Isolator 10 7 2 0 0.4795
    Myco/F Lytic, Isolator 10 6 5 0 0.0736
All bottles
    BacT/Alert MB, Myco/F Lytic 12 2 8 0.1138
    BacT/Alert MB, Isolator 10 7 3 2 1.0000
    Myco/F Lytic, Isolator 10 9 7 0 0.0233

Table 3.

Comparative times to detection of M. tuberculosis by the BacT/Alert MB system, the manual Myco/F Lytic procedure, and the Isolator 10 system

Bottle pair (bottle 1, bottle 2) No. of pairs Mean (range) time (days) to positivity
P value
Bottle 1 Bottle 2
Adequately filled bottles
    BacT/Alert MB, Myco/F Lytic 6 16.4 (9.4–21.0) 20.0 (14.9–24.0) 0.2311
    BacT/Alert MB, Isolator 10 7 16.5 (9.4–20.2) 23.8 (16.8–31.0) 0.0329
    Myco/F Lytic, Isolator 10 6 21.1 (14.9–27.0) 22.7 (16.8–28.8) 0.5554
All bottles
    BacT/Alert MB, Myco/F Lytic 12 19.0 (9.4–32.2) 24.9 (13.0–48.0) 0.0286
    BacT/Alert MB, Isolator 10 7 16.5 (9.4–20.2) 23.8 (16.8–31.0) 0.0329
    Myco/F Lytic, Isolator 10 9 24.4 (14.9–33.3) 21.8 (3.0–31.0) 0.4235

For nine Isolator 10 samples yielding M. tuberculosis, the mean (range) magnitude of mycobacteremia was 30.0 (0.4 to 90.0) CFU/ml. For seven adequately filled BacT/Alert MB and Isolator 10 bottle pairs yielding M. tuberculosis, the mean (range) time to positivity for the BacT/Alert MB system was 16.5 (9.4 to 20.2) days. The mean (range) magnitude of M. tuberculosis bacteremia determined by the Isolator 10 system was 38.2 (0.5 to 90.0) CFU/ml. There was a trend toward a longer time to positivity in the BacT/Alert MB system for samples with lower numbers of M. tuberculosis CFU/ml (r = −0.4920, r2 = 0.2420) (Fig. 1).

Fig. 1.

Fig. 1.

Relationship between the number of M. tuberculosis CFU/ml and the time to positivity in the BacT/Alert MB system.

We have demonstrated that M. tuberculosis is a leading cause of bloodstream infection among febrile inpatients in northern Tanzania (9). However, even with the continuously monitored BacT/Alert MB system, the mean time to positivity exceeded 3 weeks. The mean time to positivity for the continuously monitored BacT/Alert MB system was significantly shorter than for the Isolator 10 plated to Middlebrook 7H10 solid medium considering either adequately filled bottles or all bottles. There was a nonsignificant trend toward the continuously monitored BacT/Alert MB system having shorter times to detection than the manually read Bactec Myco/F Lytic bottle for adequately filled bottles; this difference was significant when all of the bottles were considered. While there were no statistically significant differences in sensitivity between the systems when adequately filled bottles were considered, M. tuberculosis was detected by only one member of a bottle pair on 42% of the occasions. Furthermore, consistent with other studies (3), a comparison without respect to volume adequacy showed that the Bactec Myco/F Lytic bottle was more sensitive than the Isolator 10 plated to Middlebrook 7H10 solid medium.

Whereas M. tuberculosis was detected after a mean of 22.6 days by the continuously monitored BacT/Alert MB system, M. sherrisii, the second most frequently isolated Mycobacterium species in this study (12, 23), was detected after a mean of 15.2 days by the same system. The observed differences in the time to detection between M. tuberculosis and nontuberculous mycobacteria in liquid systems may be due to constitutional differences in the rate of replication by species, differences in the optimization of the medium for the growth of different mycobacterial species, exposure to drugs with antimycobacterial activity at the time of sample collection, and the sizes of the initial inoculums of mycobacteria placed into the blood culture bottle.

The quantitative study demonstrated a wide variation in the magnitude of M. tuberculosis bacteremia in this predominantly HIV-infected population (9) of <1 CFU/ml to 90 CFU/ml. We also demonstrated a trend toward longer times to detection in the continuously monitored BacT/Alert MB system among patients with a lower magnitude of mycobacteremia. The occurrence of M. tuberculosis bacteremia at magnitudes of <1 CFU/ml may go some way toward identifying why M. tuberculosis was detected in only one member of a large proportion of many bottle pairs.

Our study had a number of limitations. In order to target the use of diagnostics to a population with higher pretest probability for disseminated tuberculosis, blood was collected for mycobacterial culture in all three blood culture systems only from patients meeting the more rigorous inclusion criteria of an oral temperature of ≥38.0°C, the presence of HIV infection, a fever duration of >1 month, and a presumed or measured weight loss of >10%. However, 10 (38.5%) of 26 participants with M. tuberculosis bloodstream infection did not meet these criteria, which resulted in some participants with M. tuberculosis bacteremia having blood inoculated into a BacT/Alert MB bottle only, thus limiting our power to compare the systems. We recommend that future studies use broader inclusion criteria, for example, focused on the presence of fever and HIV infection. The lack of availability of a Bactec continuously monitored blood culture instrument at the study site meant that Bactec Myco/F Lytic bottles had to be read manually on a daily basis, placing the Bactec Myco/F Lytic procedure at a disadvantage for comparisons of times to detection relative to the BacT/Alert MB system. To standardize volumes, we inoculated 5 ml of blood into each bottle or tube, including the Isolator 10 system, which is designed for 10 ml of blood. The lower ratio of blood to lytic agent and anticoagulant in the Isolator 10 system may have inhibited mycobacterial growth (25). However, Isolator 10 tubes were processed within 8 h of collection and the sediment was plated to solid medium rather than into broth (24).

In summary, M. tuberculosis is a common cause of bloodstream infection in northern Tanzania. Although it is detected more rapidly in a continuously monitored liquid blood culture system than by lysis-centrifugation with plating to solid medium, a mean time to positivity exceeding 3 weeks may be too long to lead to potentially lifesaving early initiation of tuberculosis treatment. The occurrence of M. tuberculosis bacteremia at magnitudes of <1 CFU/ml may contribute to long times to detection in some cases and could explain, in part, the large proportion of blood culture pairs where M. tuberculosis was isolated from only one bottle. Future work on the detection of M. tuberculosis bloodstream infection should focus on optimizing both sensitivity and time to detection. Possibly strategies could include further development of M. tuberculosis nucleic amplification techniques on large-volume peripheral blood specimens (8, 22).

Acknowledgments

This research was supported by an International Studies of AIDS-Associated Co-Infections (ISAAC) award, a United States National Institutes of Health (NIH)-funded program (U01 AI062563). We received support from NIH ISAAC awards (J.A.C., A.B.M., H.O.R., B.N.N., V.P.M.), the AIDS International Training and Research Program (D43 PA-03-018) (J.A.C., H.O.R., B.N.N., V.P.M.), the Duke Clinical Trials Unit and Clinical Research Sites (U01 AI069484) (J.A.C., V.P.M.), and the Center for HIV/AIDS Vaccine Immunology (U01 AI067854) (J.A.C.).

We thank Ahaz T. Kulanga for providing administrative support to this study and Pilli M. Chambo, Beata V. Kyara, Beatus A. Massawe, Anna D. Mtei, Godfrey S. Mushi, Lillian E. Ngowi, Flora M. Nkya, and Winfrida H. Shirima for reviewing and enrolling study participants. We are grateful to the leadership, clinicians, and patients of KCMC and MRH for their contributions to this research. We acknowledge the Hubert-Yeargan Center for Global Health at Duke University for critical infrastructure support for the KCMC-Duke University Collaboration.

Footnotes

Published ahead of print on 8 June 2011.

REFERENCES

  • 1. Archibald L. K., den Dulk M. O., Pallangyo K. J., Reller L. B. 1998. Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin. Infect. Dis. 26:290–296 [DOI] [PubMed] [Google Scholar]
  • 2. Archibald L. K., et al. 2001. Utility of paired BACTEC MYCO/F LYTIC blood culture vials for detection of bacteremia, mycobacteremia, and fungemia. J. Clin. Microbiol. 39:1960–1962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Archibald L. K., et al. 2000. Comparison of BACTEC Myco/F Lytic and Wampole Isolator 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country. J. Clin. Microbiol. 38:2994–2997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Archibald L. K., et al. 2000. A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J. Infect. Dis. 181:1414–1420 [DOI] [PubMed] [Google Scholar]
  • 5. Archibald L. K., et al. 1999. Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/=15 years old, Bangkok. J. Infect. Dis. 180:87–92 [DOI] [PubMed] [Google Scholar]
  • 6. Bell M., et al. 2001. Seasonal variation in the etiology of bloodstream infections in a febrile inpatient population in a developing country. Int. J. Infect. Dis. 5(2):63–69 [DOI] [PubMed] [Google Scholar]
  • 7. Clough M. C. 1917. The cultivation of tubercle bacilli from the circulation blood in miliary tuberculosis. Am. Rev. Tuberc. 1:598–621 [Google Scholar]
  • 8. Condos R., McClune A., Rom W. N., Schluger N. W. 1996. Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis. Lancet 347:1082–1085 [DOI] [PubMed] [Google Scholar]
  • 9. Crump J. A., et al. 2011. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania. Clin. Infect. Dis. 52:341–348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Crump J. A., Reller L. B. 2003. Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture. Clin. Infect. Dis. 37:1037–1043 [DOI] [PubMed] [Google Scholar]
  • 11. Crump J. A., Tanner D. C., Mirrett S., McKnight C. M., Reller L. B. 2003. Controlled comparison of BACTEC 13A and MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia. J. Clin. Microbiol. 41:1987–1990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Crump J. A., et al. 2009. Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg. Infect. Dis. 15:53–55 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Lewis D. K., et al. 2002. Clinical indicators of mycobacteremia in adults admitted to hospital in Blantyre, Malawi. Int. J. Tuberc. Lung Dis. 6:1067–1074 [PubMed] [Google Scholar]
  • 14. Loewenstein E. 1931. Die Züchtung der Tuberkelbazillen aus dem strömenden Blute. Zentralbl. Bakteriol. Parasitenkunde Infektionskr. Hyg. I Orig. 120:127–129 [Google Scholar]
  • 15. Lucas S. B., et al. 1993. The mortality and pathology of HIV infection in a west African city. AIDS 7:1569–1579 [DOI] [PubMed] [Google Scholar]
  • 16. McDonald L. C., Archibald L. K., Nwanyanwu O., Reller L. B., Jarvis W. R. 2000. Unrecognised Mycobacterium tuberculosis. Lancet 355:142–143 [DOI] [PubMed] [Google Scholar]
  • 17. McDonald L. C., et al. 1999. Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet 354:1159–1163 [DOI] [PubMed] [Google Scholar]
  • 18. McNemar Q. 1962. Psychological statistics, 3rd ed. John Wiley & Sons Inc., New York, NY [Google Scholar]
  • 19. Monkongdee P., et al. 2009. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am. J. Respir. Crit. Care Med. 180:903–908 [DOI] [PubMed] [Google Scholar]
  • 20. Murray P. R. 2003. Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC [Google Scholar]
  • 21. Reddy E. A., Shaw A. V., Crump J. A. 2010. Community acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 10:417–432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Schluger N. W., Condos R., Lewis S., Rom W. N. 1994. Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis. Lancet 344:232–233 [DOI] [PubMed] [Google Scholar]
  • 23. van Ingen J., et al. 2011. Mycobacterium sherrisii sp. nov.; a slow growing nonchromogenic species. Int. J. Syst. Evol. Microbiol. 61(Pt. 6):1293–1298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Wasilauskas B., Morrell R. 1994. Inhibitory effect of the Isolator blood culture system on growth of Mycobacterium avium-M. intracellulare in BACTEC 12B bottles. J. Clin. Microbiol. 32:654–657 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Wasilauskas B. L., Morrell R. M. 1997. Isolator component responsible for inhibition of Mycobacterium avium-M. intracellulare in BACTEC 12B medium. J. Clin. Microbiol. 35:588–590 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES